News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
GuruFocus.com8d agoneutral
OmniAb Inc (OABI) (Q3 2026) Earnings Call Highlights: Lilly Deal, Raised Guidance and a Busy ...The Wall Street Journal39d agoneutral
The Next Frontier for Obesity Drugs Isn’t How Much Weight You Lose, but What KindSimply Wall St.39d agoneutral
Eli Lilly (LLY) Stock Stays Undervalued As Its 437% Run Raises StakesInvestor's Business Daily39d agobullish
Move Aside Retatrutide, Eli Lilly Just Beat Its Next-Gen Obesity DrugThe Wall Street Journal39d agoneutral
Lilly’s Next-Gen Obesity Drug Helps People Lose Even More Weight in StudyMotley Fool40d agobullish
Bristol Myers Squibb vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?